Objective: To evaluate the quality of gout treatment in Lithuania. Tasks: To evaluate the influence of rheumatologist on the quality of gout treatment and the following of EULAR gout treatment recommendations: whether prophylaxis and ULT treatment were prescribed, whether Alopurinol was the first choice of ULT. To find out: the presence and frequency of gout attacks and tophi, if patients (pts) achieved the target concentration of SUA, if they have been provided with information about the importance of lifestyle changes on gout progression, and whether lifestyle has been adjusted. Methodology: The prospective cross-sectional study of pts first consulted by rheumatologist during 2013-14 yrs for gout diagnosis and treatment was carried out. Information related to pts knowledge about gout treatment, it‘s quality, risk factors, gout clinical manifestations, medications that were being used andevaluation of treatment effectiveness was evaluated. In order to evaluate the influence of rheumatologist on treatment quality, two groups of pts were compared: pts that only visited GP and pts that regularly visited a rheumatologist. Results: The answers of 69 pts were analyzed. 49.3% of pts were treated by GP only, 39.1% – by a rheumatologist, 11.6% did not visit any physician. ULT was prescribed for 84.1% of pts. For those treated with ULT, allopurinol was the first choice. Those who visited rheumatologist more often knew the target concentration of SUA (p = 0,011) but less frequently achieved it (p = 0,288); they also more often used NSAIDs to treat gout symptoms (p = 0,019). 59.4% of respondents had gout attacks during last year, 31.9% – reported having tophi. Conclusions: Although some recommendations of EULAR gout treatment guidelines have been followed, gout treatment was suboptimal in Lithuania: 1/2 of pts experienced gout attacks, 1/3 had tophi after 4 years of treatment, most pts did not know the target level of SUA, large number of them did not regularly check it, no prophylaxis or colchicine and no other ULT than xanthine oxidase inhibitors were prescribed. Pts that visited rheumatologist were more aware of the goal of treatment, but regardless of the treating physician most of them did not reach it, suggesting that there are reasons other than the doctor's influence on suboptimal treatment.